Royal Philips and University of California Collaborate to Improve Spectral Breast Imaging Screening

Royal Philips and University of California Collaborate to Improve Spectral Breast Imaging Screening
shutterstock_109294079Royal Philips recently announced a collaboration with the University of California to explore how spectral breast imaging can improve the measurement of breast density, potentially aiding clinicians with a better assessment of breast cancer risks. In the study, the researchers will use Royal Philips' spectral mammography platform called MicroDose SI. The technology was designed to address the issue of lower diagnostic accuracy of mammography for high-density breasts, and is potentially able to improve the quality of imaging for low dose diagnostics. Evidence shows that high dense breasts are at increased risk for cancer, with estimates showing that these women have a 75% increased risk of developing breast cancer when compared to women with less dense tissue. Mammography is also less accurate in detecting breast cancer in breasts with a higher density. With the use of improved technology, clinicians should be able to personalize screenings and treatments of breast cancer. Royal Philips MicroDose SI innovated spectral imaging by adding a new feature named Spectral Breast Density Measurement. The tool utilizes photon counting technology to acquire spectral data of the adipose and of fibroglandular tissue in a single exposure of a low dose mammogram, providing an a
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.